Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.9000 (0.85%) ($5.5500 - $6.0500) on Fri. Mar. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.37% (three month average) | RSI | 69 | Latest Price | $5.9000(0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(14%) TLT(14%) VCSH(13%) BND(12%) BNDX(12%) | Factors Impacting CAPR price | CAPR will decline at least -3.685% in a week (0% probabilities). XLC(-20%) QQQ(-15%) XME(-14%) URA(-14%) OIH(-13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.685% (StdDev 7.37%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
5 Day Moving Average | $5.71(3.33%) | 10 Day Moving Average | $5.32(10.9%) | 20 Day Moving Average | $4.97(18.71%) | To recent high | -13.2% | To recent low | 18% | Market Cap | $116m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |